BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2476601
,
FXYD4
,
nitric oxide metabolic process
,
Breast Cancer
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of interleukin-5 production
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bronchus
Trachea
Aorta
Thymus gland
Synovial membrane
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disease due to Orthopoxvirus
Infection due to Haemophilus
Disease due to Paramyxoviridae
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
diacetylrhein
CGP 60474
flavopiridol
BMS 387032
dinaciclib
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SOX2-OT
ITGA11
ZBTB5
BCL2A1
LEF1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
B cells from Em-myc mouse lymphomas with EZH2 shRNAs
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of interleukin-5 production
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists
A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumo…
Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing
Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ